Microsymposia diffraction studies of structural evolution, but also the study of hydrides rather than deuterides can often mitigate synthesis issues (a major issue for chemically complex materials). Breakthroughs in tackling these issues with neutron powder diffraction on modern instrumentation can have a profound effect on the study of such materials.
A series of novel 1,2,4,5,7,8-hexaoxonanes [1] , crown-containing compounds Cu(L1)2 and LiNCS.HL1 (HL1 = 4'-[2-(tosylamino) benzylideneamino]-2,3-b15c5; b15c5 = benzo-15-crown-5) [ -(L2 = terpyridine-O-CH2-b15c5, L3 = terpyridine-O-b15c5, M = Co, Ni, Cu, Zn) were structurally characterized by powder diffraction methods. For most of these compounds, it was rather difficult to obtain not only single-crystals but even crystalline powders suitable for structure determination, that required either repeat crystallizations or repeat full synthesis. Powder patterns for two compounds -Cu(L1)2 and LiNCS.HL1, respectively -were obtained using synchrotron radiation, and the rest powder patterns were obtained using the laboratory diffractometers. The fourteen new crystal structures of the aforementioned compounds were determined from powder diffraction data, which provide a reliable validation of the molecular structure for each compound. Due to the large molecular dimensions, the structure determination process did not take too much time, in contrast to the subsequent Rietveld refinement because of a large number of variables and unknown (in advance) conformations of flexible macrocycles. To overcome these obstacles in each case, a number of molecular models with various conformations of macrocycles was subjected to DFT optimization. The optimized molecular geometries were used as templates in the bond-restrained Rietveld refinement allowing a choice of the correct conformations of macrocycles.
[1] Terent'ev, A.O. et al. (2007 The anticonvulsant agent carbamazepine (CBZ) has received a lot of attention from both those interested in polymorphism and those interested in crystal structure prediction (CSP). Our own interest in CBZ spans both these disciplines; in particular, we are intrigued by the fact that predicted structures for CBZ point to the existence of a favourable C(4) catemer that has yet to be observed experimentally. Given that the C(4) catemer is observed amongst analogues of CBZ, the focus of our work has broadened to include these closely-related compounds, specifically dihydrocarbamazepine (DHC), cyheptamide (CYH) and cytenamide (CYT). This presentation will illustrate the relationships between these four compounds and, in particular, will highlight the role that SDPD has played in obtaining the crystal structures of various polymorphs. Many of the crystal structures have presented considerable challenges to SDPD (Z'=4, V ~ 2400A 3 , 72 non-H atoms, 28 DOF) both in the solution and refinement aspects. Evidence for the existence of CBZ in a C(4) catemeric configuration in a CBZ:DHC 1:1 solid solution will also be presented.
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